Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Whellan, David

< Back

Profile

djw150

David J. Whellan, MD, MHS, FACC, FAHA

Contact Dr. Whellan

1015 Chestnut Street
Suite 317
Philadelphia, PA 19107

(215) 955-2636
(215) 503-7420 fax

Medical School

MD, Washington University School of Medicine
Master Health Science in Clinical Research, Duke University

Residency

Hospital of University of Pennsylvania (HUP)

Fellowship

Clinical Cardiology, Duke University Medical Center

Board Certification

Internal Medicine
Cardiovascular Disease

Hospital Appointment

Thomas Jefferson University Hospital

Expertise & Research Interests

Dr. Whellan is the Principal Investigator of Jefferson Regional Clinical Center for the NIH HF Network, one of 9 centers across the United States selected to participate in a series of novel heart failure clinical trials. In addition, he serves as the Associate Provost for Clinical Research at Thomas Jefferson University and Associate Dean for Clinical Research at Sidney Kimmel Medical College.

He has authored over 175 peer-reviewed articles, reviews, abstracts, and book chapters on cardiomyopathy; and is an associate editor for the Journal of the American College of Cardiology Heart Failure journal.

Publications

Most Recent Peer-Reviewed Publications

  1. Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale
  2. Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes
  3. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke
  4. Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial
  5. Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION)
  6. Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: A randomized clinical trial
  7. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers
  8. Statins and Exercise Training Response in Heart Failure Patients: Insights From HF-ACTION
  9. Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012
  10. Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial
  11. Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized with Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure with Reduced and Preserved Left Ventricular Ejection Fraction
  12. Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial
  13. Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
  14. Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk
  15. Effect of early intervention with positive airway pressure therapy for sleep disordered breathing on six-month readmission rates in hospitalized patients with heart failure
  16. Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) Study
  17. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial
  18. Cognitive Outcomes After Coronary Artery Bypass Grafting
  19. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias
  20. Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee